Specific inhibition of the PKR-mediated antiviral response by the murine cytomegalovirus proteins m142 and m143.
Double-stranded RNA (dsRNA) produced during viral infection activates several cellular antiviral responses. Among the best characterized is the shutoff of protein synthesis mediated by the dsRNA-dependent protein kinase (PKR) and the oligoadenylate synthetase (OAS)/RNase L system. As viral replication depends on protein synthesis, many viruses have evolved mechanisms for counteracting the PKR and OAS/RNase L pathways. The murine cytomegalovirus (MCMV) proteins m142 and m143 have been characterized as dsRNA binding proteins that inhibit PKR activation, phosphorylation of the translation initiation factor eIF2alpha, and a subsequent protein synthesis shutoff. In the present study we analyzed the contribution of the PKR- and the OAS-dependent pathways to the control of MCMV replication in the absence or presence of m142 and m143. We show that the induction of eIF2alpha phosphorylation during infection with an m142- and m143-deficient MCMV is specifically mediated by PKR, not by the related eIF2alpha kinases PERK or GCN2. PKR antagonists of vaccinia virus (E3L) or herpes simplex virus (gamma34.5) rescued the replication defect of an MCMV strain with deletions of both m142 and m143. Moreover, m142 and m143 bound to each other and interacted with PKR. By contrast, an activation of the OAS/RNase L pathway by MCMV was not detected in the presence or absence of m142 and m143, suggesting that these viral proteins have little or no influence on this pathway. Consistently, an m142- and m143-deficient MCMV strain replicated to high titers in fibroblasts lacking PKR but did not replicate in cells lacking RNase L. Hence, the PKR-mediated antiviral response is responsible for the essentiality of m142 and m143.
Budt
Matthias
M
Division of Viral Infections, Robert Koch Institute, Nordufer 20, 13353 Berlin, Germany.
Niederstadt
Lars
L
Valchanova
Ralitsa S
RS
Jonjić
Stipan
S
Brune
Wolfram
W
D000818:Animals; D001483:Base Sequence; D015153:Blotting, Western; D003587:Cytomegalovirus / Q000378:metabolism / Q000502:physiology*; D003586:Cytomegalovirus Infections / Q000235:genetics; D004279:DNA, Viral; D015852:Eukaryotic Initiation Factor-2 / Q000378:metabolism; D005455:Fluorescent Antibody Technique; D047468:Immunoprecipitation; D051379:Mice; D008969:Molecular Sequence Data; D041681:NIH 3T3 Cells; D010766:Phosphorylation; D012330:RNA, Double-Stranded / Q000378:metabolism; D014764:Viral Proteins / Q000502:physiology*; D019892:eIF-2 Kinase / Q000037:antagonists & inhibitors* / Q000378:metabolism
D004279:DNA, Viral; D015852:Eukaryotic Initiation Factor-2; D012330:RNA, Double-Stranded; D014764:Viral Proteins; D019892:eIF-2 Kinase